FIELD: pharmacology.
SUBSTANCE: invention covers new compounds of formula I: 
or its pharmaceutically acceptable salt with antagonist activity to corticotrophin release factor (CRF). In formula (I) X means heteroaryl chosen of pyrazolyl and imidazolyl optionally substituted with (C1-C6)alkyl, haloid or phenyl; Y means -NRaRb where Ra means hydrogen, and Rb means phenyl optionally substituted with (C1-C6)alkyl or haloid; Z means (C1-C6)alkyl; and R1 means hydrogen, (C1-C6)alkyl or haloid.
EFFECT: compounds can find application in treatment, eg of neurodegenerative diseases, neuropsychiatric disorders and stresses.
19 cl, 1 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
| DERIVATIVES OF PYRAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 1993 |
|
RU2142946C1 |
| 4-AMINO-2-(4-METHYLPIPERAZINE-1-YL)-5-(2,3,5-TRICHLOROPHENYL)- -PYRIMIDINE AND ITS SALTS OF ACID ADDITION, METHODS OF THEIR SYNTHESIS (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 1989 |
|
RU2171256C2 |
| CONDENSED PIRIMIDINE DERIVATIVE AND PHARMACEUTICS WITH CRF RELATED ACTIVITY | 2004 |
|
RU2328497C2 |
| NOVEL DERIVATIVES OF 2,6-DIAMINOPYRIDIN-3-ONE | 2005 |
|
RU2385866C2 |
| PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP AS CRF ANTAGONISTS | 2005 |
|
RU2385321C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
| ANNELATED AZAHETEROCYCLIC AMIDES, WHICH INCLUDE PYRIMIDINE FRAGMENT, METHOD OF OBTAINING AND THEIR APPLICATION | 2007 |
|
RU2345996C1 |
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
| PYRROLOPYRIMIDINE COMPOUNDS AND APPLICATION THEREOF | 2011 |
|
RU2563644C2 |
